Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-10-04 00:00:00 ET · period of report 2021-10-01 · accession 0001883850-21-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-10-04 | 2021-10-01 | REGN | RYAN ARTHUR F | Dir | S - Sale | $569.49 | -100 | 23.3K | -0.4% | -$56.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-01 | S | D | 3 | $563.84 | 23,283 | D | — | — | (F3) Represents volume-weighted average price of sales of 3 shares of Company stock on October 1, 2021 at prices ranging from $563.54 to $563.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price. |
| 2 | Common | Common Stock | 2021-10-01 | S | D | 4 | $562.68 | 23,286 | D | — | — | (F2) Represents volume-weighted average price of sales of 4 shares of Company stock on October 1, 2021 at prices ranging from $562.05 to $562.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price. |
| 3 | Common | Common Stock | 2021-10-01 | S | D | 11 | $565.36 | 23,260 | D | — | — | (F5) Represents volume-weighted average price of sales of 11 shares of Company stock on October 1, 2021 at prices ranging from $565.00 to $565.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price. |
| 4 | Common | Common Stock | 2021-10-01 | S | D | 10 | $566.65 | 23,250 | D | — | — | (F6) Represents volume-weighted average price of sales of 10 shares of Company stock on October 1, 2021 at prices ranging from $566.10 to $566.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price. |
| 5 | Common | Common Stock | 2021-10-01 | S | D | 1 | $567.99 | 23,249 | D | — | — | |
| 6 | Common | Common Stock | 2021-10-01 | S | D | 1 | $568.03 | 23,248 | D | — | — | |
| 7 | Common | Common Stock | 2021-10-01 | S | D | 15 | $569.54 | 23,233 | D | — | — | (F7) Represents volume-weighted average price of sales of 15 shares of Company stock on October 1, 2021 at prices ranging from $569.07 to $569.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price. |
| 8 | Common | Common Stock | 2021-10-01 | S | D | 9 | $570.37 | 23,224 | D | — | — | (F8) Represents volume-weighted average price of sales of 9 shares of Company stock on October 1, 2021 at prices ranging from $570.00 to $570.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price. |
| 9 | Common | Common Stock | 2021-10-01 | S | D | 2 | $571.88 | 23,222 | D | — | — | (F9) Represents volume-weighted average price of sales of 2 shares of Company stock on October 1, 2021 at prices ranging from $571.81 to $571.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price. |
| 10 | Common | Common Stock | 2021-10-01 | S | D | 1 | $572.32 | 23,221 | D | — | — | |
| 11 | Common | Common Stock | 2021-10-01 | S | D | 7 | $573.54 | 23,214 | D | — | — | (F10) Represents volume-weighted average price of sales of 7 shares of Company stock on October 1, 2021 at prices ranging from $573.00 to $573.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price. |
| 12 | Common | Common Stock | 2021-10-01 | S | D | 5 | $574.33 | 23,209 | D | — | — | (F11) Represents volume-weighted average price of sales of 5 shares of Company stock on October 1, 2021 at prices ranging from $574.00 to $574.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price. |
| 13 | Common | Common Stock | 2021-10-01 | S | D | 4 | $575.41 | 23,205 | D | — | — | (F12) Represents volume-weighted average price of sales of 4 shares of Company stock on October 1, 2021 at prices ranging from $575.18 to $575.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price. |
| 14 | Common | Common Stock | 2021-10-01 | S | D | 12 | $576.34 | 23,193 | D | — | — | (F13) Represents volume-weighted average price of sales of 12 shares of Company stock on October 1, 2021 at prices ranging from $576.00 to $576.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price. |
| 15 | Common | Common Stock | 2021-10-01 | S | D | 2 | $577.27 | 23,191 | D | — | — | (F14) Represents volume-weighted average price of sales of 2 shares of Company stock on October 1, 2021 at prices ranging from $577.09 to $577.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price. |
| 16 | Common | Common Stock | 2021-10-01 | S | D | 1 | $560.51 | 23,290 | D | — | — | |
| 17 | Common | Common Stock | 2021-10-01 | S | D | 12 | $564.47 | 23,271 | D | — | — | (F4) Represents volume-weighted average price of sales of 12 shares of Company stock on October 1, 2021 at prices ranging from $564.15 to $564.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2021 at each separate price. |